Showing 6 of 206 recruiting trials for “t-cell-prolymphocytic-leukemia”
KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children
👨⚕️ Michael Pulsipher, MD, Children's Hospital Los Angeles📍 11 sites📅 Started Oct 2015View details ↗
A Long-term Extension Study of PCI-32765 (Ibrutinib)
👨⚕️ Janssen Research & Development, LLC Clinical Trial, Janssen Research & Development, LLC📍 174 sites📅 Started Sep 2013View details ↗
ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)
👨⚕️ Christina Peters, Prof. MD PhD, St. Anna Kinderspital, Vienna, Austria📍 4 sites📅 Started Apr 2013View details ↗
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
RecruitingNCT04028531 ↗
Understanding Chronic Lymphocytic Leukemia
← PreviousPage 11 of 11
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →